Dean Mitchell
Président chez PRAXIS PRECISION MEDICINES, INC.
Fortune : 2 M $ au 31/05/2024
Profil
Dean Jonathan Mitchell currently works at Praxis Precision Medicines, Inc., as Independent Chairman from 2020, Precigen, Inc., as Independent Director from 2009, and Theravance Biopharma, Inc., as Lead Independent Director.
Mr. Mitchell also formerly worked at Guilford Pharmaceuticals, Inc., as President, Chief Executive Officer & Director from 2004 to 2005, Zoetis Products LLC, as President, Chief Executive Officer & Director from 2006 to 2008, Lux Biosciences, Inc., as President, Chief Executive Officer & Director from 2010 to 2013, Alpharma LLC, as President & Chief Executive Officer from 2006 to 2008, Emergent Travel Health, Inc., as Chairman from 2016 to 2018, National Pharmaceutical Council, as Chairman, Covis Pharma Holdings BV, as Chairman from 2013 to 2020, Covis Pharma Holdings SARL, as Executive Chairman from 2013 to 2020, Paxvax Corp., as Chairman from 2016 to 2018, Kinnate Biopharma, Inc., as Chairman from 2020 to 2024, ImmunoGen, Inc., as Independent Director from 2012 to 2024, MGI PHARMA, Inc., as Non-Executive Director from 2005 to 2008, ISTA Pharmaceuticals, Inc., as Independent Director from 2004 to 2012, Talecris Biotherapeutics Holdings Corp., as Director, Bristol Myers Squibb Co., as President-International Pharmaceuticals from 2001 to 2004, GSK Plc, as Senior VP-Clinical Development & Product Strategy from 1999 to 2001, and MGI GP, Inc., as President from 2005 to 2006.
Mr. Mitchell received his undergraduate degree from Coventry University and Masters Business Admin degree from Bayes Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PRECIGEN INC
0,20% | 15/05/2024 | 503 183 ( 0,20% ) | 704 456 $ | 31/05/2024 |
THERAVANCE BIOPHARMA INC
0,17% | 08/05/2024 | 80 555 ( 0,17% ) | 694 384 $ | 31/05/2024 |
| 05/06/2024 | 5 000 ( 0,03% ) | 237 300 $ | 31/05/2024 |
Postes actifs de Dean Mitchell
| Sociétés | Poste | Début |
|---|---|---|
| PRECIGEN, INC. | Directeur/Membre du Conseil | 01/03/2009 |
| THERAVANCE BIOPHARMA, INC. | Directeur/Membre du Conseil | 01/06/2014 |
| PRAXIS PRECISION MEDICINES, INC. | Président | 17/09/2020 |
Anciens postes connus de Dean Mitchell
| Sociétés | Poste | Fin |
|---|---|---|
| KINNATE BIOPHARMA INC. | Président | 03/04/2024 |
| IMMUNOGEN, INC. | Directeur/Membre du Conseil | 12/02/2024 |
Covis Pharma Holdings SARL
 Covis Pharma Holdings SARL Financial ConglomeratesFinance Covis Pharma Holdings SARL operates as a holding company with interests in manufacturing and distribution of specialty pharmaceutical products. The company was founded in 2011 and is headquartered in Luxembourg. | Président | 01/03/2020 |
Covis Pharma Holdings BV
 Covis Pharma Holdings BV Pharmaceuticals: MajorHealth Technology Covis Pharma Holdings BV engages in the marketing and distribution of therapeutic solutions for patients with life-threatening conditions and chronic illnesses. It offers its products under the Alvesco, Omnaris, Zetonna, Altoprev, Betapace, Betapace AF, Lanoxin, Sular, Prilosec, Zanaflex, Rilutek, Tizanidine Hydrochloride, Nisoldipine, and Riluzole brands. The company was founded in December 2011 and is headquartered in Zug, Switzerland. | Président | 01/03/2020 |
| Paxvax Corp. | Président | 01/10/2018 |
Formation de Dean Mitchell
| Coventry University | Undergraduate Degree |
| Bayes Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| PRECIGEN, INC. | Health Technology |
| GSK PLC | Health Technology |
| THERAVANCE BIOPHARMA, INC. | Health Technology |
| PRAXIS PRECISION MEDICINES, INC. | Health Technology |
| Entreprise privées | 15 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
MGI PHARMA, Inc.
 MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | Health Technology |
Guilford Pharmaceuticals, Inc.
 Guilford Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Guilford Pharmaceuticals Inc. is a pharmaceutical company engaged in the research, development and commercialization of proprietary drugs that target the hospital and neurology markets. Presently, Guilford markets two commercial products, GLIADEL(R) Wafer, for the treatment of brain cancer, and AGGRASTAT(R) Injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome (ACS). Guilford's product pipeline includes a novel anesthetic, AQUAVAN(R) Injection, and drugs for treating Parkinson's disease and peripheral nerve injury | Health Technology |
Zoetis Products LLC
 Zoetis Products LLC Pharmaceuticals: MajorHealth Technology Zoetis Products LLC engaged in the manufacturing of pharmaceutical products. The company was founded in 1975 and was headquartered in Florham Park, NJ. | Health Technology |
ISTA Pharmaceuticals, Inc.
 ISTA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ISTA Pharmaceuticals, Inc. was incorporated as Advanced Corneal Systems, Inc. in California in February 1992 to discover, develop, and market new remedies for diseases and conditions of the eye. In March 2000, the company changed its name to ISTA Pharmaceuticals, Inc. It reincorporated, in Delaware, in August 2000. BROMDAY, BEPREVE, ISTALOL, VITRASE, XIBROM (bromfenac ophthalmic solution), XIBROM, T-PRED, PROLENSA, BEPOSONE, BEPOMAX, ISTA, ISTA Pharmaceuticals, Inc. and the ISTA logo are its trademarks, either owned or under license. Ista is commercial-stage, multi-specialty pharmaceutical company, which develops, markets, and sells its own products in the United States and Puerto Rico. Its products are intended to treat allergy and serious diseases of the eye and include therapies for ocular inflammation and pain, glaucoma, dry eye, and ocular and nasal allergies. | Health Technology |
Lux Biosciences, Inc.
 Lux Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Lux Biosciences, Inc. provides therapies for treatment of ophthalmic diseases. It develops and commercializes medications for ophthalmic diseases. The company was founded by Ulrich M. Grau, Eddy Anglade, Clarke A. Atwell and Sidney L. Weiss in 2006 and is headquartered in Jersey City, NJ. | Health Technology |
Emergent Travel Health, Inc.
 Emergent Travel Health, Inc. Internet Software/ServicesTechnology Services Emergent Travel Health, Inc. develops vaccines against infectious diseases. The firm develops vaccines against typhoid, cholera, hepatitis, anthrax, and other infectious diseases. Its proprietary adenoviral-based technology platform enables the rapid development of oral vaccines that can target viral or bacterial protein antigen. The company was founded by Kenneth Kelley and Daniel R. Henderson in 2007 and is headquartered in San Diego, CA. | Technology Services |
Talecris Biotherapeutics Holdings Corp.
 Talecris Biotherapeutics Holdings Corp. BiotechnologyHealth Technology Talecris Biotherapeutics Holdings Corp. develops and markets plasma-derived protein therapy products. The company was founded in 1942 and is headquartered in Research Triangle Park, NC. | Health Technology |
National Pharmaceutical Council
 National Pharmaceutical Council Miscellaneous Commercial ServicesCommercial Services The National Pharmaceutical Council operates as a not for profit organization. It specializes in research development, information dissemination, education, and communication of information to patients. The company was founded in 1953 and is headquartered in Washington, DC. | Commercial Services |
| MGI GP, Inc. | |
Covis Pharma Holdings BV
Covis Pharma Holdings BV Pharmaceuticals: MajorHealth Technology Covis Pharma Holdings BV engages in the marketing and distribution of therapeutic solutions for patients with life-threatening conditions and chronic illnesses. It offers its products under the Alvesco, Omnaris, Zetonna, Altoprev, Betapace, Betapace AF, Lanoxin, Sular, Prilosec, Zanaflex, Rilutek, Tizanidine Hydrochloride, Nisoldipine, and Riluzole brands. The company was founded in December 2011 and is headquartered in Zug, Switzerland. | Health Technology |
Covis Pharma Holdings SARL
Covis Pharma Holdings SARL Financial ConglomeratesFinance Covis Pharma Holdings SARL operates as a holding company with interests in manufacturing and distribution of specialty pharmaceutical products. The company was founded in 2011 and is headquartered in Luxembourg. | Finance |
| Alpharma LLC | |
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA. | Health Technology |
| Paxvax Corp. |
